Abstract
Overabundance of extracellular matrix resulting from hyperproliferation of keloid fibroblasts (KFs) and dysregulation of apoptosis represents the main pathophysiology underlying keloids. High-mobility group box 1 (HMGB1) plays important roles in the regulation of cellular death. Suppression of HMGB1 inhibits autophagy while increasing apoptosis. Suppression of HMGB1 with glycyrrhizin has therapeutic benefits in fibrotic diseases. In this study, we explored the possible involvement of autophagy and HMGB1 as a cell death regulator in keloid pathogenesis. We have highlighted the potential utility of glycyrrhizin as an antifibrotic agent via regulation of the aberrant balance between autophagy and apoptosis in keloids. Higher HMGB1 expression and enhanced autophagy were observed in keloids. The proliferation of KFs was decreased following glycyrrhizin treatment. While apoptosis was enhanced in keloids after glycyrrhizin treatment, autophagy was significantly reduced. The expressions of ERK1/2, Akt, and NF-κB, were enhanced in HMGB1-teated fibroblasts, but decreased following glycyrrhizin treatment. The expression of extracellular matrix (ECM) components was reduced in glycyrrhizin-treated keloids. TGF-β, Smad2/3, ERK1/2, and HMGB1 were decreased in glycyrrhizin-treated keloids. Treatment with the autophagy inhibitor 3-MA resulted in a decrease of autophagy markers and collagen in the TGF-β-treated fibroblasts. The results indicated that autophagy plays an important role in the pathogenesis of keloids. Because glycyrrhizin appears to reduce ECM and downregulate autophagy in keloids, its potential use for treatment of keloids is indicated.
Highlights
Keloids, considered benign fibroproliferative tumors that culminate in abnormal dermal fibrosis, are characterized by the excessive deposition of extracellular matrix (ECM)
An overabundance of ECM resulting from uncontrolled proliferation of keloid fibroblasts (KFs) is one of the most well-known causative factors involved in keloid development [2,3,4,5,6,7]
We focused on the autophagy of keloids in regulating fibrogenesis, along with possible involvement of High-mobility group box 1 (HMGB1)
Summary
Keloids, considered benign fibroproliferative tumors that culminate in abnormal dermal fibrosis, are characterized by the excessive deposition of extracellular matrix (ECM). These tumors invade adjacent normal tissue and rarely regress spontaneously [1]. There has been increasing interest in the field of pathological scars, and several mediators have been found to influence the pathogenesis of keloids, albeit without a clear understanding of the underlying mechanism. It has commonly been assumed that keloid formation is caused by increased cellular proliferation and reduced rate of apoptosis in KFs [8,9,10]. Appropriate therapies may be directed at either inhibiting proliferation of KFs or reversing pathological fibrosis
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
